Investigating cellular similarities and differences between upper tract urothelial carcinoma and bladder urothelial carcinoma using single-cell sequencing
Q Zhang, C Wang, M Qin, Y Ye, Y Mo, Q Meng… - Frontiers in …, 2024 - frontiersin.org
Background Upper tract urothelial carcinoma (UTUC) and bladder urothelial carcinoma
(BLCA) both originate from uroepithelial tissue, sharing remarkably similar clinical …
(BLCA) both originate from uroepithelial tissue, sharing remarkably similar clinical …
[HTML][HTML] WIP1-mediated regulation of p38 MAPK signaling attenuates pyroptosis in sepsis-associated acute kidney injury
Y Wang, C Cui, W Zhao, X Tian, P Liu, L Wei, Z Zhu… - Immunobiology, 2024 - Elsevier
Abstract Wild-Type p53-Induced Phosphatase 1 (WIP1/PPM1D) is a serine/threonine
phosphatase that plays a significant role in various physiological processes. However, the …
phosphatase that plays a significant role in various physiological processes. However, the …
Transcriptomic insights into UTUC: role of inflammatory fibrosis and potential for personalized treatment
K Li, Z Huang, G Xie, B Huang, L Song, Y Zhang… - Journal of Translational …, 2024 - Springer
Background Upper tract urothelial carcinoma (UTUC) is a rare disease, belonging to the
same category of urothelial cancers as bladder cancer (BC). Despite sharing similar non …
same category of urothelial cancers as bladder cancer (BC). Despite sharing similar non …
Inherited Germline Variants in Urinary Tract Cancer: A Multicenter Whole-Exome Sequencing Analysis and Correlation With Clinical Features and Tumor Genomics
W Kohlmann, DA Nix, K Pauley, S Greenberg… - JCO Precision …, 2024 - ascopubs.org
PURPOSE This study investigates a real-world multicenter cohort of patients with urinary
tract cancer (UTC), with primary disease sites including the bladder, urethra, and upper tract …
tract cancer (UTC), with primary disease sites including the bladder, urethra, and upper tract …
Multi‑omics approach to improve patient‑tailored therapy using immune checkpoint blockade and cytokine‑induced killer cell infusion in an elderly patient with lung …
Y Xing, F Qin, L Han, J Yang, H Zhang… - Oncology …, 2024 - spandidos-publications.com
The 5‑year survival rate of patients with advanced non‑small cell lung cancer (NSCLC)
remains low, despite recent advances in targeted therapy and immunotherapy. Therefore …
remains low, despite recent advances in targeted therapy and immunotherapy. Therefore …
[HTML][HTML] Absence of GATA3/FOXA1 co-expression predicts poor prognosis in upper tract urothelial carcinoma
Y Wang, Y Wang, H He, Y Xiong - Frontiers in Oncology, 2024 - frontiersin.org
Objective GATA binding protein 3 (GATA3) and forkhead box A1 (FOXA1) have been
individually implicated in the progression of upper tract urothelial carcinoma (UTUC). This …
individually implicated in the progression of upper tract urothelial carcinoma (UTUC). This …
[HTML][HTML] Hub biomarkers in ultrasound-guided bladder cancer and osteosarcoma: Myosin light chain kinase and caldesmon
H Li, G Lin, M Cui, L Wang, D Ding, X Li, X Fan… - Medicine, 2023 - journals.lww.com
Bladder cancer and osteosarcoma are 2 types of cancers that originate from epithelial
tissues inside the bladder and bone or muscle tissues. Ultrasound-guided biopsies provide …
tissues inside the bladder and bone or muscle tissues. Ultrasound-guided biopsies provide …
复发性膀胱癌的多学科联合诊疗及文献复习
刘磊， 张远鹏， 樊继全， 苏扬波， 周迪炜… - 临床泌尿外科 …, 2023 - lcmw.whuhzzs.com
本文介绍1 例在经过膀胱癌根治术后出现复发的肌层浸润性膀胱癌患者的多学科联合诊疗(MDT)
过程. 该患者在诊断性电切明确病理诊断后, 行新辅助化疗+ 免疫治疗, 病灶出现部分缓解 …
过程. 该患者在诊断性电切明确病理诊断后, 行新辅助化疗+ 免疫治疗, 病灶出现部分缓解 …
[PDF][PDF] Research Progress of New Urine Markers in the Diagnosis of Bladder Cancer
R Lamichhane - DNA - auo.asmepress.com
Bladder cancer is the tenth most commonly diagnosed cancer worldwide and poses a great
threat to human health. It has a high recurrence rate and requires long-term close monitoring …
threat to human health. It has a high recurrence rate and requires long-term close monitoring …
The Efficacy of Radiotherapy for Retroperitoneal Metastasis Upper Tract Urothelial Carcinoma: Patterns of Metastasis and Proposals for the Delineation of Clinical …
X Li, XS Gao, C Xu, Q Tang, K Yang, S Qin, F Lv, M Liu… - papers.ssrn.com
Objective: To investigate the efficacy of radiotherapy in upper tract urothelial carcinoma
(UTUC) patients with retroperitoneal lymph node metastasis. Materials and Methods: We …
(UTUC) patients with retroperitoneal lymph node metastasis. Materials and Methods: We …